Mee Yon Lee1, Kyu Seop Kim, Won Ki Lee. 1. Department of Ophthalmology, Seoul St. Mary's Hospital,College of Medicine, The Catholic University of Korea, Seoul, Korea.
Abstract
PURPOSE: To report of a case of acute retinal necrosis (ARN), successfully treated with intravitreal foscarnet. METHODS: Case report. RESULTS: A 40-year-old man diagnosed with varicella zoster virus (VZV)-induced ARN failed standard acyclovir treatment. He was treated subsequently with intravenous foscarnet, but developed acute renal failure after 1 day of treatment. All systemic anti-viral agents were discontinued, and intravitreal foscarnet was administered weekly. After 5 injections, the retinitis was dramatically improved. CONCLUSIONS: Intravitreal foscarnet was efficacious in the treatment of acyclovir-resistant ARN caused by VZV. It may be used as the sole treatment in patients with intolerance to systemic administration.
PURPOSE: To report of a case of acute retinal necrosis (ARN), successfully treated with intravitreal foscarnet. METHODS: Case report. RESULTS: A 40-year-old man diagnosed with varicella zoster virus (VZV)-induced ARN failed standard acyclovir treatment. He was treated subsequently with intravenous foscarnet, but developed acute renal failure after 1 day of treatment. All systemic anti-viral agents were discontinued, and intravitreal foscarnet was administered weekly. After 5 injections, the retinitis was dramatically improved. CONCLUSIONS: Intravitreal foscarnet was efficacious in the treatment of acyclovir-resistant ARN caused by VZV. It may be used as the sole treatment in patients with intolerance to systemic administration.
Authors: Waseem H Ansari; Francesco Pichi; Paula E Pecen; Careen Y Lowder; Sunil K Srivistava Journal: Int Ophthalmol Date: 2017-04-22 Impact factor: 2.031
Authors: Gail E Reid; Joseph P Lynch; Samuel Weigt; David Sayah; John A Belperio; Shellee A Grim; Nina M Clark Journal: Semin Respir Crit Care Med Date: 2016-08-03 Impact factor: 3.119